Skip to main content
Top
Published in: Rheumatology International 8/2011

01-08-2011 | Original Article

Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting

Authors: Li Long, Ru Li, Yongzhe Li, Chaojun Hu, Zhanguo Li

Published in: Rheumatology International | Issue 8/2011

Login to get access

Abstract

The objective of this study was to search for proteomic patterns distinguishing patients with rheumatoid arthritis (RA) from healthy controls, biomarker candidates specific for early RA, and proteins reflecting disease activity, by profiling of serum proteins using magnetic bead-based (MB) separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Magnetic chemical affinity beads were used to differentially capture serum proteins prior to MALDI-TOF analysis. Seventy serum samples from patients with RA and 50 from healthy controls were analyzed. The samples were randomly allocated to the training set or test set to develop a pattern by means of decision tree algorithm. ANOVA test was utilized to search for biomarkers for early RA. Pearson correlation analysis was employed to estimate the overexpressed peaks in relation to Disease Activity Score (DAS)28. The algorithm identified a pattern based on 3 peaks (m/z 2,490, 5,910.07, 6,436.73) that, in the training set, separated patients with RA from healthy controls with a sensitivity and specificity of 87.5 and 96.7%, respectively. Blind test data indicated a sensitivity of 86.7% and specificity of 90%. The peaks of m/z 1,014.92 and 1,061.38 were raised significantly in early RA group (disease duration <12 months) compared with those in non-early RA group (disease duration ≥12 months) and healthy controls. A positive correlation was found between the intensity of peak 9,591.47 and DAS28 scores. Using MB separation followed by MALDI-TOF–MS enabled rapid diagnosis of RA according to fingerprint pattern, a method which might also help to assess disease activity and identify early RA.
Literature
1.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
2.
go back to reference Saraux A, Berthelot JM, Chales G et al (2001) Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 44:2485–2491PubMedCrossRef Saraux A, Berthelot JM, Chales G et al (2001) Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 44:2485–2491PubMedCrossRef
3.
go back to reference Harrison BJ, Symmons DP, Barrett EM et al (1998) The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 25:2324–2330PubMed Harrison BJ, Symmons DP, Barrett EM et al (1998) The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 25:2324–2330PubMed
4.
go back to reference Hulsemann JL, Zeidler H (1999) Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic. Ann Rheum Dis 58:278–280PubMedCrossRef Hulsemann JL, Zeidler H (1999) Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic. Ann Rheum Dis 58:278–280PubMedCrossRef
5.
go back to reference Liao KP, Batra KL, Chibnik L et al (2008) Anti-CCP revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis 67:1557–1561PubMedCrossRef Liao KP, Batra KL, Chibnik L et al (2008) Anti-CCP revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis 67:1557–1561PubMedCrossRef
6.
go back to reference Visser H, Cessie Sl, Vos K et al (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRef Visser H, Cessie Sl, Vos K et al (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRef
7.
go back to reference Schlesier B, Mock HP (2006) Protein isolation and second-dimension electrophoretic separation. Methods Mol Biol 323:381–391PubMed Schlesier B, Mock HP (2006) Protein isolation and second-dimension electrophoretic separation. Methods Mol Biol 323:381–391PubMed
8.
go back to reference Vimalachandran D, Costello E (2004) Proteomic technologies and their application to pancreatic cancer. Expert Rev Proteomics 1(4):493–501PubMedCrossRef Vimalachandran D, Costello E (2004) Proteomic technologies and their application to pancreatic cancer. Expert Rev Proteomics 1(4):493–501PubMedCrossRef
9.
go back to reference Villanueva J, Philip J, Entenberg D et al (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76:1560–1570PubMedCrossRef Villanueva J, Philip J, Entenberg D et al (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76:1560–1570PubMedCrossRef
10.
go back to reference Freed GL, Cazares LH, Fichandler CE et al (2008) Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope 118(1):61–68PubMedCrossRef Freed GL, Cazares LH, Fichandler CE et al (2008) Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope 118(1):61–68PubMedCrossRef
11.
go back to reference Scott DL (2002) The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 46(2):286–290PubMedCrossRef Scott DL (2002) The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 46(2):286–290PubMedCrossRef
12.
go back to reference Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140:659–662PubMed Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140:659–662PubMed
13.
go back to reference Prevoo ML, vant’ Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, vant’ Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
14.
go back to reference Wells GA, Becker JC, Teng J, et al (2008) Validation of the disease activity score 28 (DAS28) and EULAR response criteria based on CRP against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on ESR. Ann Rheum Dis 68(6):954–960PubMedCrossRef Wells GA, Becker JC, Teng J, et al (2008) Validation of the disease activity score 28 (DAS28) and EULAR response criteria based on CRP against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on ESR. Ann Rheum Dis 68(6):954–960PubMedCrossRef
15.
go back to reference Zhukov TA, Johanson RA, Cantor AB et al (2003) Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 40:267–279PubMed Zhukov TA, Johanson RA, Cantor AB et al (2003) Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 40:267–279PubMed
16.
go back to reference Won Y, Song HJ, Kang TW et al (2003) Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 3:2310–2316PubMedCrossRef Won Y, Song HJ, Kang TW et al (2003) Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 3:2310–2316PubMedCrossRef
17.
go back to reference Cheng AJ, Chen LC, Chien KY et al (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51(12):2236–2244PubMedCrossRef Cheng AJ, Chen LC, Chien KY et al (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51(12):2236–2244PubMedCrossRef
18.
go back to reference Peter JF, Otto AM, Wolf B (2007) Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS. J Biomol Tech 18(5):287–297PubMed Peter JF, Otto AM, Wolf B (2007) Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS. J Biomol Tech 18(5):287–297PubMed
19.
go back to reference Fiedler GM, Baumann S, Leichtle A, et al (2007) Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 53(3):421–428PubMedCrossRef Fiedler GM, Baumann S, Leichtle A, et al (2007) Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 53(3):421–428PubMedCrossRef
20.
go back to reference de Seny D, Fillet M, Meuwis MA et al (2005) Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 52(12):3801–3812PubMedCrossRef de Seny D, Fillet M, Meuwis MA et al (2005) Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 52(12):3801–3812PubMedCrossRef
21.
go back to reference Liu W, Li X, Ding F, Li Y (2008) Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis. Scand J Rheumatol 37(2):94–102PubMedCrossRef Liu W, Li X, Ding F, Li Y (2008) Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis. Scand J Rheumatol 37(2):94–102PubMedCrossRef
Metadata
Title
Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting
Authors
Li Long
Ru Li
Yongzhe Li
Chaojun Hu
Zhanguo Li
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1407-4

Other articles of this Issue 8/2011

Rheumatology International 8/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine